The Intellectual Property Debate: Perspectives from Law, Economics and Political Economy
Meir Perez Pugatch
Edward Elgar Publishing, Jan 1, 2006 - Law - 392 pages
. . . a lovely little book which is full of telling points. Read it and you won t be disappointed. Jeremy Phillips, IPkat.com Meir Pugatch has done an excellent job by assembling an international and diverse cast of contributing authors, who have offered
What people are saying - Write a review
1 A critical analysis of the TRIPS agreement
2 The TRIPS agreement the damage to the WTO
3 Can stronger intellectual property rights boost trade foreign direct investment and licensing in developing countries?
an EU perspective of a global question
PART II IPRs business and publicprivate partnerships
5 What is an idea worth?
strategic management implications for SMEs
11 Patenting genes
PART IV IPRs competition access and antitrust in the age of the information society
12 Balancing intellectual property rights and competition law in a dynamic knowledgebased European economy
the stakeholders in the Kazaa era1
the end of the public domain or constitutional reconceptualization?
PART V IPRs and geographical indications
15 Geographical indications and TRIPS
16 The treatment of geographical indications in recent regional and bilateral free trade agreements
7 Encouraging cooperation among the academic government and private sectors in US biomedical RD
is it time for a Bayh Dole Modernization Act?
PART III IPRs pharmaceuticals and biotechnology
a global public good?
10 The realities of TRIPS patents and access to medicines in developing countries
activities aﬀect agricultural application Article 82 Bayh-Dole Act beneﬁts biomedical biotechnology BRCA1 cash ﬂows claims commercial companies competition law compulsory licensing conﬂict consumer copy copyright law costs Court debate decision deﬁned deﬁnition developing countries diﬀerent diﬃcult Doha Declaration drugs economic eﬀect eﬀorts enforcement European Commission example Federal ﬁeld ﬁle ﬁnancial ﬁnd ﬁrms ﬁrst ﬁve gene patents gene sequence geographical indications global Grokster identiﬁed imatinib mesylate implementation important inﬂuence infringement innovation intellectual property rights inventive step IPRs issue Journal licensing medicines ment Michael Blakeney monopoly Napster obligations oﬀered Oﬃce Orphan Drug parties patent system private sector problem proﬁts protein public domain real option method reﬂect Regulation relation right-holders signiﬁcant speciﬁc standards strategic suﬃcient technology transfer tion trade trademarks TRIPS agreement wines WIPO
Page 1 - Provided also and be it declared and enacted* That any declaration before mentioned shall not extend to any letters patents and grants of privilege for the term of fourteen years or under hereafter to be made of the sole working or making of any manner of new manufactures within this realm to the true and first inventor and inventors of such manufactures which others at the time of making such letters patents and grants shall not use, so as also they be not contrary to the law nor mischievous to...
Page 1 - Realm, to the true and first Inventor and Inventors of such Manufactures, which others at the Time of Making such Letters Patents and Grants shall not use, so as also they be not contrary to the Law, nor mischievous to the State, by raising Prices of Commodities at home, or Hurt of Trade, or generally inconvenient...